{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:44:48Z","timestamp":1790225088900,"version":"4.1.0"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,2,2]]},"DOI":"10.18632\/oncotarget.23989","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T04:28:39Z","timestamp":1515212919000},"page":"8531-8541","source":"Crossref","is-referenced-by-count":59,"title":["Genetic alterations in main candidate genes during melanoma progression"],"prefix":"10.18632","volume":"9","author":[{"given":"Maria Cristina","family":"Sini","sequence":"first","affiliation":[{"name":"Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Doneddu","sequence":"additional","affiliation":[{"name":"Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Paliogiannis","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Casula","sequence":"additional","affiliation":[{"name":"Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Colombino","sequence":"additional","affiliation":[{"name":"Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Manca","sequence":"additional","affiliation":[{"name":"Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Botti","sequence":"additional","affiliation":[{"name":"Istituto Nazionale Tumori, Fondazione Pascale, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo A.","family":"Ascierto","sequence":"additional","affiliation":[{"name":"Istituto Nazionale Tumori, Fondazione Pascale, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Lissia","sequence":"additional","affiliation":[{"name":"Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cossu","sequence":"additional","affiliation":[{"name":"Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palmieri","sequence":"additional","affiliation":[{"name":"Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"1","article-title":"Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy","author":"Palmieri","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jnci\/djh136","article-title":"Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families","volume":"96","author":"Demenais","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/CEJ.0000000000000334","article-title":"Vitamin D status and risk for malignant cutaneous melanoma: recent advances","volume":"26","author":"Palmieri","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"4","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Parkin","year":"2010","journal-title":"Int J Cancer"},{"key":"5","unstructured":"Globocan 2012. Estimated cancer incidence, mortality and prevalence worldwide 2012. http:\/\/globocan.iarc.fr\/Default.aspx [last accessed 15\/01\/2017]."},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.4512","article-title":"Analysis of Trends in US Melanoma Incidence and Mortality","author":"Rigel","year":"2016","journal-title":"JAMA Dermatol"},{"key":"7","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Gimotty","year":"2009","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Ewing","year":"2002","journal-title":"Nature"},{"key":"9","first-page":"183","article-title":"Multiple molecular pathways in melanomagenesis: characterization of therapeutic targets","volume":"5","author":"Cossu","year":"2015","journal-title":"Front Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/BC.2005.025","article-title":"Oncogenic Ras in tumour progression and metastasis","volume":"386","author":"Giehl","year":"2005","journal-title":"Biol Chem"},{"key":"11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1479-5876-7-86","article-title":"Main roads to melanoma","volume":"7","author":"Ascierto","year":"2009","journal-title":"J Transl Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Peeper","year":"2005","journal-title":"Nature"},{"key":"13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1479-5876-12-117","article-title":"Discrepant alterations in main candidate genes among multiple primary melanomas","volume":"12","author":"Mazzoni","year":"2014","journal-title":"J Transl Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jid.2016.05.103","article-title":"Low levels of genetic heterogeneity in matched lymph node metastases from patients with melanoma","volume":"136","author":"Rubino","year":"2016","journal-title":"J Invest Dermatol"},{"key":"15","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1158\/1535-7163.MCT-08-0431","article-title":"Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas","volume":"7","author":"Herlyn","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"16","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1158\/1078-0432.CCR-06-2682","article-title":"Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response","volume":"13","author":"Becker","year":"2007","journal-title":"Clin Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/CMR.0000000000000195","article-title":"Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival","volume":"25","author":"Salti","year":"2015","journal-title":"Melanoma Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/gcc.22378","article-title":"Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases","volume":"55","author":"Stenzinger","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2011.41.2452","article-title":"BRAF\/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma","volume":"30","author":"Manca","year":"2012","journal-title":"J Clin Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejca.2017.06.028","article-title":"Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017","volume":"83","author":"Schadendorf","year":"2017","journal-title":"Eur J Cancer"},{"key":"21","volume-title":"A Small molecule inhibitor of the MITF molecular pathway. Probe reports from the NIH molecular libraries program","author":"Munoz","year":"2010"},{"key":"22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Li","year":"2005","journal-title":"Nature"},{"key":"23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Dummer","year":"2008","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1755-148X.2008.00480.x","article-title":"Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage","volume":"21","author":"Fisher","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V","article-title":"Specificity within the EGF family\/ErbB receptor family signaling network","volume":"20","author":"Stern","year":"1998","journal-title":"BioEssays"},{"key":"26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/376337a0","article-title":"Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor","volume":"376","author":"Derynck","year":"1995","journal-title":"Nature"},{"key":"27","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/ijc.22928","article-title":"EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis","volume":"121","author":"Bal\u00e1zs","year":"2007","journal-title":"Int. J Cancer"},{"key":"28","first-page":"2170","article-title":"Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization","volume":"58","author":"Pinkel","year":"1998","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CMR.0000000000000123","article-title":"EGFR and cyclin D1 in nodular melanoma: correlation with pathohistological parameters and overall survival","volume":"24","author":"Zamolo","year":"2014","journal-title":"Melanoma Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature02820","article-title":"Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control","volume":"430","author":"Cordon-Cardo","year":"2004","journal-title":"Nature"},{"key":"31","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Roberts","year":"1999","journal-title":"Genes Dev"},{"key":"32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<358::AID-PATH452>3.0.CO;2-1","article-title":"Expression of p16 and lack of pRB in primary small cell lung cancer","volume":"189","author":"Strebhardt","year":"1999","journal-title":"J Pathol"},{"key":"33","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.humpath.2013.01.025","article-title":"Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations","volume":"44","author":"Ortonne","year":"2013","journal-title":"Hum Pathol"},{"key":"34","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"14","author":"West","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Bastian","year":"2006","journal-title":"J Clin Oncol"},{"key":"36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1471-2407-9-352","article-title":"Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy","volume":"9","author":"Palmieri","year":"2009","journal-title":"BMC Cancer"},{"key":"37","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0959-8049(02)00152-1","article-title":"Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer","volume":"38","author":"Palmieri","year":"2002","journal-title":"Eur J Cancer"},{"key":"38","first-page":"243","article-title":"Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma","volume":"158","author":"Lissia","year":"2008","journal-title":"Br J Dermatol"},{"key":"39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1746-1596-1-19","article-title":"Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescencehybridization assay","volume":"1","author":"Varella-Garcia","year":"2006","journal-title":"Diagn. Pathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:34:53Z","timestamp":1589024093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,2,2]]}},"alternative-id":["23989","29492214"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23989","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,3]]}}}